Phase I study of weekly schedule of oxaliplatin, high-dose leucovorin and infusional fluorouracil in pretreated patients with advanced colorectal cancer.

被引：0
|
作者：
Rosati, G [1 ]
Rossi, A [1 ]
Bilancia, D [1 ]
Manzione, L [1 ]
机构：
[1] San Carlo Hosp, Med Oncol Unit, Potenza, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
H53
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [1] Phase I study of weekly schedule of oxaliplatin, high-dose leucovorin and infusional fluorouracil in pretreated patients with advanced colorectal cancer.
    Rosati, G
    Rossi, A
    Manzione, L
    ANNALS OF ONCOLOGY, 2000, 11 : 56 - 57
  • [2] Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer
    Rosati, G
    Rossi, A
    Tucci, A
    Pizza, C
    Manzione, L
    ANNALS OF ONCOLOGY, 2001, 12 (05) : 669 - 674
  • [3] Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer
    Chiara, S
    Nobile, MT
    Gozza, A
    Taveggia, P
    Heouaine, A
    Pastrone, I
    Percivale, PL
    Lionetto, R
    Sanguineti, O
    Rosso, R
    ANTICANCER RESEARCH, 2004, 24 (01) : 355 - 360
  • [4] Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancer
    Vanhoefer, U
    Harstrick, A
    Köhne, CH
    Achterrath, W
    Rustum, YM
    Seeber, S
    Wilke, H
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 907 - 913
  • [5] Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC)
    Kouroussis, C
    Souglakos, J
    Mavroudis, D
    Papadouris, S
    Kakolyris, S
    Agelaki, S
    Kalbakis, K
    Panopoulos, C
    Vardakis, N
    Sarra, E
    Georgoulias, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (06): : 627 - 631
  • [6] Oxaliplatin, leucovorin and fluorouracil in pretreated patients with advanced colorectal cancer.
    deGramont, A
    Tournigand, C
    Louvet, C
    Andre, T
    Molitor, JL
    Raymond, E
    Moreau, S
    Vignoud, J
    LeBail, N
    Krulik, M
    REVUE DE MEDECINE INTERNE, 1997, 18 (10): : 769 - 775
  • [7] Oxaliplatin with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced colorectal cancer patients: A phase II study
    Yang, TS
    Chen, JS
    Tang, RP
    Chiang, JM
    Hsieh, PS
    Yeh, CY
    Changchien, CR
    CHEMOTHERAPY, 2003, 49 (04) : 194 - 199
  • [8] A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer
    Rosati, G
    Tucci, A
    Rinaldi, A
    Colarusso, D
    Pizza, C
    Reggiardo, G
    Manzione, L
    ONCOLOGY, 2004, 66 (05) : 371 - 378
  • [9] Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study
    Pectasides, D
    Pectasides, A
    Farmakis, D
    Bountouroglou, N
    Nikolaou, M
    Koumpou, M
    Mylonakis, N
    Kosmas, C
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 537 - 542
  • [10] Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer
    Yamada, Y
    Ohtsu, A
    Boku, N
    Miyata, Y
    Shimada, Y
    Doi, T
    Muro, K
    Muto, M
    Hamaguchi, T
    Mera, K
    Yano, T
    Tanigawara, Y
    Shirao, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (04) : 218 - 223
12345